Clicky

mobile btn
Wednesday, May 15th, 2024

Biological

Funds target additional sensor system development

ENSCO, Inc. has secured an 18-month, $2.9 million Department of Homeland Security (DHS) Science and Technology Directorate (S&T) contract to continue sensor system development initiatives. ENSCO's work would focus on SenseNet, an endeavor devoted to developing a low-cost integrated sensor... Read More »

Twist Bioscience touts Battelle biosecurity technology

The synthetic biology firm Twist Bioscience Corporation is espousing the benefits of Battelle's ThreatSEQTM web service DNA screening platform, which is designed to aid in bolstering internal biosecurity efforts. “Battelle created the ThreatSEQ web service with significant input from industry... Read More »

CALS training initiative deemed successful

Applied science and technology development company Battelle has deemed the recent three-week testing of its Common Analytical Laboratory System (CALS) with users a success. CALS, described as three variants of mobile laboratories providing on-site analytical capabilities to any incident... Read More »

New index offers tool to monitor global disease outlook

A new global index offers an original way to monitor national-level preparedness for infectious disease, providing a holistic view of a country’s capacity to mitigate the spread of illness and pandemics. Created by researchers at Metabiota, the Epidemic Preparedness Index (EPI) factors... Read More »

Emergent applies for FDA approval of anthrax vaccine

Emergent BioSolutions submitted an application to the U.S. Food and Drug Administration (FDA) for potential emergency use of a new anthrax vaccine the company recently developed. The vaccine, called NuThrax, is being developed as an anthrax vaccine for post-exposure prophylaxis of disease... Read More »

Biodefense Institute names new lab director

The Battelle National Biodefense Institute (BNBI) recently named George W. Korch, Jr. as lab director of the National Biodefense Analysis and Countermeasures Center (NBACC). Korch is a member of the American Association for the Advancement of Science and has a Ph.D. in Immunology and Infectious... Read More »

NTI holds meeting to identify, address biological risks

Policy leaders and scientific experts met in November to assess the impact of advances in technology on biological risks and brainstorm new ideas to address them. The meeting -- sponsored by the Nuclear Threat Initiative (NTI), Oxford University, and Johns Hopkins University -- included... Read More »

Air Force field testing new protective mask

The U.S. Air Force completed field testing last month of an improved chemical, biological, radiological and nuclear (CBRN) protective mask for crews on rotary wing aircraft. The Joint Service Aircrew Mask – Rotary Wing replaces the Aircrew Eye and Respiratory Protection system on HH-60G Pave... Read More »

Groups seek funds countering biological threats

The Nuclear Threat Initiative (NTI) has joined over 60 global health security organizations in calling for bolstered funding in the Trump Administration’s 2020 budget request to counter biological threats. The groups forwarded correspondence to Secretary of Health and Human Services and Chair... Read More »

Biosecurity firm Battelle wins R&D 100 award

Battelle was awarded earlier this month a 2018 R&D 100 Award for its creation of a web-based DNA screening platform for the detection and characterization of sequences of concern in genomic data. The award-winning technology – called ThreatSEQ – is a commercial DNA screening solution that... Read More »

Merck nears approval of experimental Ebola vaccine

Merck has started the submission of a rolling Biologics License Application to the U.S. Food and Drug Administration for an investigational vaccine to combat the Zaire strain of the Ebola virus, the company recently announced. The V920 vaccine, scientifically known as rVSV-ZEBOV, falls under... Read More »